Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115154
Status:
COMPLETED
Last Update Posted:
2007-02-19
First Post:
2005-06-21
Brief Title:
Study to Assess the Safety and Efficacy of Imiquimod 5 Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Sponsor:
Graceway Pharmaceuticals LLC
Organization:
Graceway Pharmaceuticals LLC
Study Overview
Official Title:
Vehicle-Controlled Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5 Cream for the Treatment of Actinic Keratosis on the Upper Extremities
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of imiquimod 5 cream compared to vehicle cream in the treatment of Actinic Keratosis AK on the arm andor hand when the cream is applied once daily 2 days per week for 16 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None